InCube Ventures

Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles.

BiotechDigital HealthHealthtechMedical DevicesSan Jose, US

Mir Hashim(Executive Officer, Director)in

BoardMir Imran(Founder)Andrew Farquharson(Director)

Co-investorsRA CapitalVHM

Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.

HealthtechMedical DevicesRoboticsSilicon Valley, US

Alex Tilson(Founder & CEO)in

Co-investorsSonder CapitalMighty CapitalShangBay Capital LLC

Pioneered endocardial mapping and ablation technologies for cardiac arrhythmias; acquired by Boston Scientific.

Early-stage company developing a novel therapy for atrial fibrillation.

Developing novel treatments for gastrointestinal disorders including Crohn's disease and ulcerative colitis.

Early-stage company developing a novel transdermal therapy for iron deficiency anemia.

Developing a remote patient monitoring system to wirelessly manage patients with active implants.

Developing a gastric stimulation product platform (abiliti) for the treatment of obesity.

Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.

BiotechDeep TechMedical DevicesBerkeley, US

Brian Thomas(Executive Officer, Director, Promoter)in

BoardAndrew Farquharson(Director)Jak Knowles(Director)

Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more

Early-stage company developing a novel therapy for the treatment of epilepsy.

Developed the LUNA embolization device for brain aneurysms; acquired by Covidien (then Medtronic).

Pioneered embolic protection in interventional cardiology with its Guardwire product; acquired by Medtronic.

Developed neuro-diagnostic devices including depth-of-anesthesia sensors; went public in 1996 and later acquired by Hospira.

Developing innovations for gastrointestinal disorders, including post-surgical leak resolution and bioresorbable healing devices.

Developing a disruptive technology for oral delivery of biologics.

Co-investorsSamsara BioCapital

Medical technology company developing a neuromodulation system to treat overactive bladder (OAB).

Developed mm-wave radar imaging technology for homeland security screening; acquired by L-3 Communications in 2006.

Biotechnology company developing therapeutics that target the extracellular matrix in acute and chronic diseases.

BiotechSan Francisco, US

KENNETH N. HORNE(Executive Officer, Director)ALYSSA PANITCH(Director)JOHN PADERI(Director)KATE STUART(Executive Officer)

Co-investorsMitsui Global InvestmentAlly Bridge GroupLilly Ventures

A medtech company developing a platform focused on treating neurological conditions and neurotherapeutics.

Deep TechHealthtechMedical Devices

Developed a non-surgical transurethral needle ablation therapy for benign prostatic hyperplasia; acquired by Medtronic.

Developed compact ultrasound systems using Zone Sonography imaging; acquired by Mindray.

Co-investorsApposite Capital